Skip to main content
Log in

Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

With escalating focus on cost containment, there is increasing scrutiny on the practice of multiple stereotactic radiosurgeries (SRSs) for patients with cerebral metastases distant to the initial tumor site. Our goal was to determine the survival patterns of patients with cerebral metastasis who underwent multiple SRSs. We retrospectively analyzed survival outcomes of 801 patients with 3683 cerebral metastases from primary breast, colorectal, lung, melanoma and renal histologies consecutively treated at the University of California, San Diego/San Diego Gamma Knife Center (UCSD/SDGKC), comparing the survival pattern of patients who underwent a single (n = 643) versus multiple SRS(s) (n = 158) for subsequent cerebral metastases. Findings were recapitulated in an independent cohort of 2472 patients, with 26,629 brain metastases treated with SRS at the Katsuta Hospital Mito GammaHouse (KHMGH). For the UCSD/SDGKC cohort, no significant difference in median survival was found for patients undergoing 1, 2, 3, or ≥4 SRS(s) (median survival of 167, 202, 129, and 127 days, respectively). Median intervals between treatments consistently ranged 140–178 days irrespective of the number of SRS(s) (interquartile range 60–300; p = 0.25). Patients who underwent >1 SRSs tend to be younger, with systemic disease control, harbor lower cumulative tumor volume but increased number of metastases, and have primary melanoma (p < 0.001, <0.001, <0.001, 0.02, and 0.009, respectively). Comparable results were found in the KHMGH cohort. Using an independent validation study design, we demonstrated comparable overall survival between judiciously selected patients who underwent a single or multiple SRS(s).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698–2705

    Article  PubMed  Google Scholar 

  2. Davis FG, Dolecek TA, McCarthy BJ, Villano JL (2012) Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro Oncol 14:1171–1177. doi:10.1093/neuonc/nos152

    Article  PubMed  PubMed Central  Google Scholar 

  3. Suh JH, Videtic GM, Aref AM, Germano I, Goldsmith BJ, Imperato JP, Marcus KJ, McDermott MW, McDonald MW, Patchell RA, Robins HI, Rogers CL, Wolfson AH, Wippold FJ 2nd, Gaspar LE (2010) ACR appropriateness criteria: single brain metastasis. Curr Probl Cancer 34:162–174. doi:10.1016/j.currproblcancer.2010.04.003

    Article  PubMed  Google Scholar 

  4. Lutterbach J, Cyron D, Henne K, Ostertag CB (2003) Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 52:1066–1073; discussion 1073–1064

  5. Kondziolka D, Kano H, Harrison GL, Yang HC, Liew DN, Niranjan A, Brufsky AM, Flickinger JC, Lunsford LD (2011) Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. J Neurosurg 114:792–800. doi:10.3171/2010.8.JNS10461

    Article  PubMed  Google Scholar 

  6. Stelzer KJ (2013) Epidemiology and prognosis of brain metastases. Surg Neurol Int 4:S192–S202. doi:10.4103/2152-7806.111296

    PubMed  PubMed Central  Google Scholar 

  7. Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, Sanders M, Young AB (2002) Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 52:333–338

    Article  PubMed  Google Scholar 

  8. Marko NW, Weil RJ (2010) The role of observational investigations in comparative effectiveness research. Value Health 13:989–997

    Article  PubMed  Google Scholar 

  9. Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, Asher AL, Loeffler JS, Robinson PD, Andrews DW, Gaspar LE, Kondziolka D, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Patchell RA, Kalkanis SN (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96. doi:10.1007/s11060-009-0055-6

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ancestry.com (1935–2011) United States Social Security Death Index, 2012

  11. Pan H, Cervino LI, Pawlicki T, Jiang SB, Alksne J, Detorie N, Russell M, Carter BS, Murphy KT, Mundt AJ, Chen C, Lawson JD (2012) Frameless, real-time, surface imaging-guided radiosurgery: clinical outcomes for brain metastases. Neurosurgery 71:844–851. doi:10.1227/NEU.0b013e3182647ad5

    Article  PubMed  Google Scholar 

  12. Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Moots PL, Mrugala MM, Newton HB, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Wen PY, McMillian NR, Ho M (2014) Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. J Natl Compr Cancer Netw 12:1517–1523

    Google Scholar 

  13. Lau SK, Zakeri K, Zhao X, Carmona R, Knipprath E, Simpson DR, Nath SK, Kim GY, Sanghvi P, Hattangadi-Gluth JA, Chen CC, Murphy KT (2015) Single-isocenter frameless volumetric modulated arc radiosurgery for multiple intracranial metastases. Neurosurgery 77:233–240; discussion 240. doi:10.1227/NEU.0000000000000763

  14. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672. doi:10.1016/S0140-6736(04)16250-8

    Article  PubMed  Google Scholar 

  15. Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Nariai T, Watanabe S, Barfod BE, Kasuya H (2014) Validity of prognostic grading indices for brain metastasis patients undergoing repeat radiosurgery. World Neurosurg 82:1242–1249. doi:10.1016/j.wneu.2014.08.008

    Article  PubMed  Google Scholar 

  16. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  17. Cox D (1972) Regression models and life tables. J R Stat Soc Ser B 34(2):187–220. Retrieved from http://www.jstor.org/stable/2985181

  18. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    Article  CAS  PubMed  Google Scholar 

  19. Gonda DD, Kim TE, Goetsch SJ, Kawabe T, Watanabe S, Alksne JF, Hattangadi JA, Nitta M, Ott K, Hodgens DW, Carter BS, Yamamoto M, Chen CC (2014) Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration. Eur J Cancer 50:1148–1158. doi:10.1016/j.ejca.2014.01.001

    Article  CAS  PubMed  Google Scholar 

  20. Ishihara K, Saida T, Otsuka F, Yamazaki N, Prognosis, Statistical Investigation Committee of the Japanese Skin Cancer S (2008) Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 13:33–41. doi:10.1007/s10147-007-0751-1

    Article  Google Scholar 

  21. American Academy of Actuaries (2008) Health insurance coverage and reimbursement decisions: implications for increased comparative effectiveness research. American Academy of Actuaries, Washington

  22. Lal LS, Byfield SD, Chang EL, Franzini L, Miller LA, Arbuckle R, Reasonda L, Feng C, Adamus A, Swint JM (2012) Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases. Am J Clin Oncol 35:45–50. doi:10.1097/COC.0b013e3182005a8f

    Article  PubMed  Google Scholar 

  23. Hall MD, McGee JL, McGee MC, Hall KA, Neils DM, Klopfenstein JD, Elwood PW (2014) Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases. J Neurosurg 121(Suppl):84–90. doi:10.3171/2014.7.GKS14972

    PubMed  Google Scholar 

  24. Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, Yamanaka K, Sato Y, Jokura H, Yomo S, Nagano O, Kenai H, Moriki A, Suzuki S, Kida Y, Iwai Y, Hayashi M, Onishi H, Gondo M, Sato M, Akimitsu T, Kubo K, Kikuchi Y, Shibasaki T, Goto T, Takanashi M, Mori Y, Takakura K, Saeki N, Kunieda E, Aoyama H, Momoshima S, Tsuchiya K (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395. doi:10.1016/S1470-2045(14)70061-0

    Article  PubMed  Google Scholar 

  25. Marcus L, Marshall D, Hirshman B, McCutcheon B, Gonda D, Koiso T, Hattangadi-Gluth J, Carter B, Yamamoto M, Chen C (2015) Cumulative intracranial tumor volume (CITV) enhances the prognostic value of the lung-specific graded prognostic assessment (GPA) model. Neurosurgery. doi:10.1227/NEU.0000000000001123

    PubMed  Google Scholar 

  26. McDuff SG, Taich ZJ, Lawson JD, Sanghvi P, Wong ET, Barker FG 2nd, Hochberg FH, Loeffler JS, Warnke PC, Murphy KT, Mundt AJ, Carter BS, McDonald CR, Chen CC (2013) Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry 84:1384–1391. doi:10.1136/jnnp-2013-305166

    Article  PubMed  Google Scholar 

  27. Gonda DD, Kim TE, Warnke PC, Kasper EM, Carter BS, Chen CC (2012) Ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis. Surg Neurol Int 3:97. doi:10.4103/2152-7806.100185

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chen CC, Kasper E, Warnke P (2011) Palliative stereotactic-endoscopic third ventriculostomy for the treatment of obstructive hydrocephalus from cerebral metastasis. Surg Neurol Int 2:76. doi:10.4103/2152-7806.82083

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044. doi:10.1016/S1470-2045(09)70263-3

    Article  PubMed  Google Scholar 

  30. Wang CC, Floyd SR, Chang CH, Warnke PC, Chio CC, Kasper EM, Mahadevan A, Wong ET, Chen CC (2012) Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. J Neurooncol 106:601–610. doi:10.1007/s11060-011-0697-z

    Article  PubMed  Google Scholar 

  31. Press RH, Prabhu RS, Nickleach DC, Liu Y, Shu HK, Kandula S, Patel KR, Curran WJ, Crocker I (2015) Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases. Cancer 121:3836–3843. doi:10.1002/cncr.29590

    Article  PubMed  Google Scholar 

  32. Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD (2014) A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol 16:1283–1288. doi:10.1093/neuonc/nou018

    Article  PubMed  PubMed Central  Google Scholar 

  33. Karlsson B, Hanssens P, Wolff R, Soderman M, Lindquist C, Beute G (2009) Thirty years’ experience with Gamma Knife surgery for metastases to the brain. J Neurosurg 111:449–457. doi:10.3171/2008.10.JNS08214

    Article  PubMed  Google Scholar 

  34. Chen JC, Petrovich Z, Giannotta SL, Yu C, Apuzzo ML (2000) Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurgery 46:860–866; discussion 866–867

  35. Madajewicz S, Karakousis C, West CR, Caracandas J, Avellanosa AM (1984) Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer 53:2550–2552. doi:10.1002/1097-0142(19840601)53:11<2550:AID-CNCR2820531129>3.0.CO;2-B

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded in part by the National Institutes of Health (TL1TR00098 to D.C.M.; KL2TR00099 to J.H.G.; and, UL1TR000100 to J.H.G.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clark C. Chen.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study formal consent is not required. The study protocol was approved by the Institutional Review Board.

Additional information

Masaaki Yamamoto and Clark C. Chen are equal contributions as senior authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 105 kb)

Supplementary material 2 (PDF 180 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marshall, D.C., Marcus, L.P., Kim, T.E. et al. Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries. J Neurooncol 128, 119–128 (2016). https://doi.org/10.1007/s11060-016-2084-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2084-2

Keywords

Navigation